Effects of riluzole on harmaline induced tremor and ataxia in rats: Biochemical, histological and behavioral studies

European Journal of Pharmacology

Volumn 695, Issue 1-3, 2012, Pages 40-47

  Rahimi Shourmasti, Fatemeh ^a   Goudarzi, Iran ^a   Lashkarbolouki, Taghi ^a   Abrari, Kataneh ^a   Elahdadi Salmani, Mahmoud ^a   Goudarzi, Afsaneh ^a  

^a DAMGHAN UNIVERSITY   (Iran)

Author keywords

(Rat); Cerebellum; Harmaline; Riluzole; Tremor

Indexed keywords

RILUZOLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; CEREBELLUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; HISTOPATHOLOGY; MOTOR PERFORMANCE; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PURKINJE CELL; RAT; ROTAROD TEST; TREMOR;

ANIMALS; ATAXIA; BEHAVIOR, ANIMAL; CEREBELLUM; GLUTAMATES; HARMALINE; ION CHANNELS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RILUZOLE; ROTAROD PERFORMANCE TEST; TIME FACTORS; TREMOR;

EID: 84867575467     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.08.014     Document Type: Article

References (49)

1. M. Arshaduddin, S. Al Kadasah, N. Biary, S. Al Deeb, K. Al Moutaery, and M. Tariq Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats Behav. Brain. Res. 153 2004 15 20
2. R.D. Azbill, X. Mu, and J.E. Springer Riluzole increases high affinity glutamate uptake in rat spinal cord synaptosomes Brain Res. 871 2000 175 180
3. A.R. Bausch, and G. Roy Volume-sensitive chloride channels blocked by neuroprotective drugs in human glial cells (U-138MG) Glia 18 1996 73 77
4. A.J. Beitz, and D. Saxon Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway J. Neurocytol. 33 2004 49 74
5. E. Benoit, and D. Escande Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre Pflugers Arch. 419 1991 603 609
6. G. Bensimon, L. Lacomblez, and V.A. Meininger Controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group N. Engl. J. Med. 330 1994 585 591
7. N. Biary, M. Arshaduddin, S. Al Deeb, K. Al Moutaery, and M. Tariq Effect of lidocaine on harmaline-induced tremors in the rat Pharmacol. Biochem. Behav. 65 2000 117 121
8. P. Breton, J.C. Bizot, J. Bueeand, and I. De La Manche Brain neurotoxicity of penitrem a: electrophysiological, behavioral and histopathological study Toxicon 36 1998 645 655
9. M.E. Burger, R. Fachinetto, G. Zeni, and J.B. Rocha Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain Pharmacol. Biochem. Behav. 81 2005 608 615
10. D.W. Choi Glutamate neurotoxicity and diseases of the nervous system Neuron 1 1988 623 634
11. C. De Montigny, and Y. Lamarre Activity in the olivo-cerebello-bulbar system of the cat during ibogaline- and oxotremorine-induced tremor Brain Res. 82 1974 369 373
12. C. De Montigny, and Y. Lamarre Rhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat Brain Res. 53 1973 81 95
13. M.W. Debono, J. Le Guern, T. Canton, A. Doble, and L. Pradier Inhibition of riluzole of electrophysiological response mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes Eur. J. Pharmacol. 235 1993 283 289
14. A. Doble The role of excitotoxicity in neurodegenerative disease: implications for therapy Pharmacol. Ther. 81 1999 163 221
15. W. Du, V.J. Aloyo, and J.A. Harvey Harmaline competitively inhibits H MK-801binding to the NMDA receptor in rabbit brain Brain Res. 770 1997 26 29
16. F. Eblen, P.A. Loschmann, U. Wullner, L. Turski, and T. Klockgether Effects of 7 nitroindazole, NG-nitro-l-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-d-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions Eur. J. Pharmacol. 28 1996 9 16
17. A.G. Estevez, J.M. Stutzmann, and L. Barbeito Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures Eur. J. Pharmacol. 280 1995 47 53
18. T. Hebert, P. Drapeau, L. Pradier, and R.J. Dunn Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole Mol. Pharmacol. 45 1994 1055 1060
19. J.P. Hubert, J.C. Delumeau, J. Glowinski, J. Premont, and A. Doble Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action Br. J. Pharmacol. 113 1994 261 267
20. + channel in cultured rat cerebellar Purkinje neurons Eur. J. Neurosci. 11 1999 735 739
21. M. Janahmadi, I. Goudarzi, M.R. Kaffashian, G. Behzadi, Y. Fathollahi, and S. Hajizadeh Co-treatment with riluzole, a neuroprotective drug, ameliorates the 3-acetylpyridine-induced neurotoxicity in cerebellar Purkinje neurons of rats: behavioural and electrophysiological evidence Neurotoxicology 30 2009 393 402
22. T. Jehle, J. Bauer, E. Blauth, A. Hummel, M. Darstein, T.M. Feuerstein, and T.J. Feuerstein Effects of riluzole on electrically evoked neurotransmitter release Br. J. Pharmacol. 130 2000 1227 1234
23. J.H. Kim, J.Y. Jun, H.J. You, K.H. Kee, J.W. Oh, Y.T. Kim, and I.Y. Chang Degenerative change of cerebellar Purkinje cells by harmaline treatment Korean J. Phys. Anthropol. 16 2003 39 49
24. L. Lacomblez, G. Bensimon, P.N. Leigh, P. Guillet, and V. Meininger Dose-ranging study of riluzole in amyotrophic lateral sclerosis: amyotrophic lateral sclerosis/riluzole study group II Lancet 374 1996 1425 1431
25. Y. Lamarre, C. De Montigny, M. Dumont, and M. Weiss Harmaline-indu∼ rhythmic activity of cerebellar and lower brain stem neurons Brain Res. 32 1971 246 250
26. Y. Lamarre, and M. Weiss Harmaline-induced rhythmic activity of alpha and gamma motoneurons in the cat Brain Res. 63 1973 430 434
27. Y. Lamarre, and L.A. Mercier Neurophysiological studies of harmaline induced tremor in the cat Can. J. Physiol. Pharmacol. 49 1971 1049 1058
28. I. Lampl, and Y. Yarom Subthreshold oscillations and resonant behavior: two manifestations of the same mechanism Neuroscience 78 1997 325 341
29. R. Llinás, and R.A. Volkind The olivo-cerebellar system: functional properties as revealed by harmaline-induced tremor Exp. Brain Res. 18 1973 69 87
30. E.D. Louis Essential tremor Lancet Neurol. 4 2005 100 110
31. M.B. MacIver, S.M. Amagasu, A.A. Mikulec, and F.A. Monroe Riluzole anesthesia: use-dependent block of presynaptic glutamate fibers Anesthesiology 85 1996 626 634
32. C. Malgouris, F. Bardot, M. Daniel, F. Pellis, J. Rataud, A. Uzan, J.C. Blanchard, and P.M. Laduron Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils J. Neurosci. 9 1989 3720 3727
33. J. Málly, M. Baranyi, and E.S. Vizi Change in the concentrations of amino acids in CSF and serum of patients with essential tremor J. Neural Transm. 103 1996 555 560
34. D. Martin, M.A. Thompson, and J.V. Nadler The neuroprotective agent riluzole inhibits release of glutamate and aspirate from slices of hippocampal area CA1 Eur. J. Pharmacol. 250 1993 473 476
35. V. Mary, F. Wahl, and J.M. Stutzmann Effect of riluzole on quinolate-induced neural damage in rats: comparison with blockers of glutamate neurotransmission Neurosci. Lett. 201 1995 92 96
36. K.M. Noh, J.Y. Hwang, H.C. Shin, and J.Y. Koh A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C Neurobiol. Dis. 7 2000 375 383
37. E. O'Hearn, and M.E. Molliver Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline Neuroscience 55 1993 303 310
38. E. O'Hearn, and M.E. Molliver The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity J. Neurosci. 17 1997 8828 8841
39. E. O'Hearn, and M.E. Molliver Neurotoxins and neuronal death: an animal model of excitotoxicity V.E. Koliatsos, R.R. Ratan, Cell Death and Diseases of the Nervous System 1999 Human Press Inc. Totowa, NJ 221 245
40. H. Ogura, T. Mikami, N. Takamura, Y. Suzuki, and T. Chiba Development of behavioral function of cerebellar hypoplasia rats as induced by cytosine arabinoside (ara-C) Nippon Yakurigaku Zasshi 76 1980 33 44
41. J.W. Olney Neurotoxicity of excitatory amino acids E.G. McGeer, J.W. Olney, P.O. McGeer, Kainic Acid as a Tool in Neurobiology 1978 95 171
42. R. Pahwa, and K.E. Lyons Essential tremor: differential diagnosis and current therapy Am. J. Med. 115 2003 134 142
43. H.H. Pennes, and P.H. Hoch Psychotomimetics, clinical and theoretical considerations: harmine, WIN-2299 and Nalline Am. J. Psychiatry 113 1957 887 892
44. J.H. Song, C.S. Huang, K. Nagata, J.Z. Yeh, and T. Narahashi Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin- resistant sodium channels J. Pharmacol. Exp. Ther. 282 1997 707 714
45. J.M. Stutzmann, F. Wahl, J. Pratt, V. Mary, M. Reibaud, E. Tecoult, and J. Rataud Neuroprotective profile of riluzole in vivo models of acute neurodegenerative diseases CNS Drugs Rev. 3 1997 83 101
46. C.E. Van Skike, P. Botta, V.S. Chin, S. Tokunaga, J.M. McDaniel, J. Venard, J.L. Diaz-Granados, C.F. Valenzuela, and D.B. Matthews Behavioral effects of ethanol in cerebellum are age dependent: potential system and molecular mechanisms Alcohol. Clin. Exp. Res. 34 2010 2070 2080
47. Y. Watanabe, K. Kinoshita, A. Koguchi, and M. Yamamura A new method for evaluation of motor deficits in 3-acetylpyridine-treated rats J. Neurosci. Methods 77 1997 25 29
48. H. Wilms, J. Sievers, and G. Deuschl Animal models of tremor Mov. Disord. 14 1999 557 571
49. G. Zetler, G. Back, and H. Iven Pharmacokinetics in the rat of the hallucinogenic alkaloids harmine and harmaline Naunyn Schmiedebergs Arch. Pharmacol. 285 1974 273 292